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Abstract 
Introduction 
Retaining clients in residential alcohol and other drug (AOD) treatment is difficult and 
cognitive impairment has been identified as a significant predictor of treatment dropout. The 
application of extensive screening for cognitive impairment is cost-prohibitive for most AOD 
treatment services. The current study aimed to explore cognitive functioning and impairment-
associated factors in a typical sample of residential AOD clients using a free brief screening 
tool that could be utilised by front-line AOD services.  
Methods 
Residents of an AOD therapeutic community (n = 128) and a non-substance using control 
group (n = 37) were administered a brief cognitive screening measure, the Montreal 
Cognitive Assessment (MoCA). MoCA total and domain scores were compared between 
these groups and within the AOD group examined in association with primary substance of 
misuse, severity of dependence, gender, psychological distress, and history of head injury. 
Results 
Almost half (43.8%) of the AOD sample were identified as cognitively impaired, compared 
to 16.2% of the control group. Furthermore, 67.2% of the AOD sample had sustained head 
injuries and 50% of the sample required hospitalisation for head injury. History of head 
injury was a significant determinant of cognitive impairment, and associated with greater 
levels of psychological distress. 
Conclusions 
There are high rates of inter-related cognitive impairment, head injuries, and psychological 
distress among clients in residential AOD treatment. Routine screening of clients at intake for 
cognitive impairment by means of a brief screening measure such as the MoCA, in 
combination with the assessment of history of head injuries and comorbid psychological 
disorders, could inform treatment modifications or adjunct interventions to increase retention 
and improve long-term outcomes. 
 
 
Key words: substance misuse; cognitive impairment; therapeutic community; residential 
treatment; cognitive screening; head injury 
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1. Introduction 
Therapeutic communities (TCs) are a form of residential rehabilitation for individuals 
experiencing chronic and severe alcohol and other drug (AOD) problems and may 
particularly suit clients with associated comorbidities and other complexities as they place an 
emphasis on fostering social support within the community of residents in order to promote 
treatment engagement and completion. Dropout from AOD treatment in general is estimated 
to be as high as 57% in inpatient settings (Darke, Campbell, & Popple, 2012a; Deane, 
Wootton, Hsu, & Kelly, 2012; Vergara-Moragues, Gonzalez-Saiz, Lozano, & Verdejo 
Garcia, 2013). Importantly, length of stay in TCs has been shown to be related to 
neurocognitive capacity (Fals-Stewart & Lucente, 1994; Fals-Stewart & Schafer, 1992; 
Fernández-Serrano, Pérez-García, Perales, & Verdejo-García, 2010a). An extensive 
systematic review reported that cognitive deficits were one of the most consistently reported 
risk factors for dropout from AOD treatment, alongside personality disorder, low treatment 
alliance, and younger age (Brorson, Ajo Arnevik, Rand-Hendriksen, & Duckert, 2013). 
 It is likely that most residential substance misuse programs deliver treatments that 
work optimally in those who possess intact cognitive abilities; that cognitive impairment 
among residents may hinder treatment success requires further consideration. Components of 
residential AOD treatment often rely on capacities such as executive function (defined 
broadly as “those capacities that enable a person to engage successfully in independent, 
purposive, self-directed, and self-serving behavior”; Lezak, Howieson, Bigler, & Tranel, 
2012, p. 37) and working memory (Fernández-Serrano et al., 2010b; Yücel & Lubman, 
2007), as clients are required to integrate new information, formulate goals, establish new 
behavioural strategies, and plan for the future in overcoming addiction. 
 However, most misused substances impair attention, learning and memory, 
visuospatial abilities, and executive functioning, with perhaps the most robust deficits across 
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all substances evident in inhibitory control, working memory, and decision-making 
(Fernández-Serrano, Pérez-García, Río-Valle, & Verdejo-García, 2010b; Yücel & Lubman, 
2007; Yücel, Lubman, Solowij, & Brewer, 2007). Structural and functional brain changes 
may occur after substance misuse (Broyd, van Hell, Yücel, & Solowij, in press; Caplan, 
Epstein, Quinn, Stevens, & Stern, 2007; Ersche & Sahakian, 2007; Gonzalez, 2007; Gruber, 
Silveri, & Yurgelun-Todd, 2007; Lorenzetti, Solowij, & Yücel, in press; Oscar-Berman & 
Marinkovic, 2007; Scott et al., 2007). Traumatic brain injury (TBI) is also highly prevalent in 
substance misuse populations, leading to significant complexities in the process of AOD 
treatment (Sacks et al., 2009; Solomon & Malloy, 1992; Walker, Cole, Logan, & Corrigan, 
2007; West, 2011). 
Although cognitive dysfunction is common in AOD samples and increasingly 
recognised by staff, there is often insufficient time or resources to implement detailed 
neuropsychological assessments. Cognitive assessment may be instrumental in facilitating the 
detection of AOD clients with clinically significant cognitive impairment, irrespective of 
aetiology. Assessing clients’ cognitive capacities can inform subsequent implementation of 
strategies aimed at improving treatment retention and outcomes. 
In the AOD treatment environment a brief but valid and reliable measure is required. 
This would provide an indication of potential cognitive dysfunction and alert staff to the 
possibility that further neuropsychological assessment and/or treatment modifications may be 
indicated. The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) comprises 
12 items that tap five key neuropsychological domains: executive function, working memory, 
short-term memory, language, and visuospatial ability. The MoCA takes 15 minutes to 
administer, is a free resource (Nasreddine, 2014), and can be administered by staff without 
formal neuropsychological training. Initial studies have found evidence supporting the use of 
the MoCA in AOD treatment settings (Copersino et al., 2009; Copersino et al., 2012). 
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 The current study was exploratory in nature and sought to provide a naturalistic 
overview of a sample of Australian TC residents, with the MoCA administered as a brief 
screening measure to assess neuropsychological functioning. Performance on the MoCA was 
investigated in relation to demographic, substance use, psychological, and other variables 
related to impairments in cognition, including TBI. 
 
2. Material and methods 
2.1 Participants 
 The AOD group was recruited from We Help Ourselves (WHOs), a large provider of 
residential AOD treatment in Australia that uses the Therapeutic Community model of 
treatment. Participants were recruited across seven WHOs sites in New South Wales 
(Sydney, Hunter Valley) and Queensland (Sunshine Coast). The response rate was 
approximately 90%. Specific inclusion and exclusion criteria were not applied in order to 
capture the heterogeneous and complex presentations of residential AOD treatment 
populations and to increase the generalisability of results. Although there was no formal 
assessment of substance use disorders using the Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM–5; American Psychiatric Association, 2013) criteria it was assumed 
that residents would meet these criteria given their attendance at a high-intensity residential 
program. 
A control group was recruited through University of Wollongong College, a provider 
of educational programs to persons who have not completed highschool matriculation, as an 
alternative pathway to tertiary study. All students were invited to participate and the response 
rate was approximately 60%. Control participants, all native English speakers, were excluded 
for any lifetime dependence on or treatment for alcohol or other drugs, and any psychiatric or 
neurological diagnoses. 
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2.2 Procedure  
 After a group information session, interested participants provided written consent 
and were individually assessed in a quiet testing room. This was conducted within the TC 
facility for the AOD group, and at a University psychology clinic for the control group. The 
MoCA was administered in approximately 15 minutes, adhering to the administration and 
scoring guidelines (Nasreddine, 2014). Additional information (e.g., basic demographics, 
history of head injury, current and past substance use for controls) was obtained through a 
ten-minute semi-structured interview and the Kessler Psychological Distress Scale (K10; 
Kessler et al., 2002) was administered, as well as the Severity of Dependence Scale (SDS; 
Gossop et al., 1995) for the AOD group. Control participants received a $20 gift card as 
reimbursement for their time. 
2.3 Measures 
2.3.1 MoCA 
 The MoCA was used to assess neuropsychological functioning across its purported 
five domains (executive function, working memory, short-term memory, language and 
visuospatial ability). Executive function is assessed using trail-making, phonemic fluency, 
and verbal abstraction tasks. Working memory is assessed using sustained attention, serial 
subtraction, and digit span forwards/backwards tasks. Short-term memory is assessed through 
the delayed recall of five nouns. Language is assessed using naming (low familiarity 
animals), sentence repetition, and the phonemic fluency task. Visuospatial ability is assessed 
using clock-drawing and cube-copying tasks. The MoCA has displayed acceptable reliability 
in clinical groups (Bernstein, Lacritz, Barlow, Weiner, & DeFina, 2011; Freitas, Simões, 
Marôco, Alves, & Santana, 2012). Outcome measures included total MoCA score and 
domain subscores. 
2.3.2 Clinical variables 
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The SDS (Gossop, Best, Marsden, & Strang, 1997) measured AOD participants’ level 
of dependence on their primary substance of misuse. The K10 was used to capture level of 
psychological distress experienced by all participants. The K10 has been extensively used in 
both community and clinical samples as an indicator of a potential psychological disorder, 
and has demonstrated acceptable psychometric properties (George, Kinner, Bruno, 
Degenhardt, & Dunn, 2010; Hides et al., 2007; Sunderland, Mahoney, & Andrews, 2012). 
Relevant demographic and substance use data routinely collected by WHOs were accessed, 
following participants and the director of the service providing written consent. 
2.4 Data analysis 
All data were analysed using IBM Statistical Package for the Social Sciences (version 
19; IBM Corp, 2010). The primary goals of the analysis were to compare the performance of 
residents and controls on the MoCA and to explore variation in MoCA scores and potential 
predictors (e.g., primary substance of misuse, gender effects) within the AOD sample. 
Shapiro-Wilk statistics and visual inspection of histograms and boxplots determined 
that total MoCA score, MoCA domain subscores, age, years of education, K10 and SDS 
scores were not normally distributed for both AOD and control groups. Consequently, 
nonparametric techniques were employed for most of the analyses. Nonparametric analysis of 
covariance was required for some analyses to enable covarying demographic characteristics 
that differed between groups. Quade’s (1967) distribution-free procedure was used as a 
nonparametric alternative to analysis of covariance (see Olejnik & Algina, 1985). This 
involved ranking the dependent variable and all covariates for all cases, ignoring the grouping 
variable. Following this, the linear regression of the ranked dependent variable on the ranked 
covariate measure was calculated and the unstandardised residuals saved, again ignoring the 
grouping factor. To calculate Quade’s F statistic, a one-way analysis of variance using the 
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residuals from the regression as the dependent variable and the grouping variable as the factor 
was performed. 
 Total MoCA score and cognitive domain subscores were the primary dependent 
variables for analysis. However, factor analyses of the MoCA have demonstrated that 
domains may be grouped differently (e.g., Duro, Simões, Ponciano, & Santana, 2010; Freitas 
et al., 2012). Given the multi-process nature of neuropsychological tasks, whereby any single 
task may tap into a range of perceptual, cognitive and motor abilities, and the overlapping 
nature of the cognitive domains assessed by the MoCA (Freitas et al., 2012), we created an 
additional score for analysis of executive function. This was of particular interest because 
executive dysfunction is especially common in substance misusing individuals (e.g., 
Fernández-Serrano et al., 2010b; Gierski et al., 2013; Hester, Lubman, & Yϋcel, 2010; Perry 
et al., 2011). As such, we utilised the standard measure of executive function from the MoCA 
as well as an extended measure that included performance on the visuospatial cube-copying 
and clock-drawing tasks, with the rationale that these tasks rely on key component processes 
of executive function. 
 All AOD residents were compared to controls in the first instance. Residents were 
then compared in terms of gender and primary substance of misuse. Primary substance of 
misuse groupings were formed by choosing the three largest representative groups in 
residence at the time of testing (alcohol, heroin and amphetamines). A broader opiates group 
was then formed by the addition of clients on methadone maintenance and buprenorphine 
users. Cocaine users, minimal in Australian AOD samples (Australian Institute of Health and 
Welfare, 2005), were grouped with amphetamine users to form a stimulants group. This 
strategy maximised group sizes for comparison, grouping together substances with similar 
chemical properties. However, primary users of cannabis, tranquilisers and benzodiazepines 
were not grouped or included in these comparisons due to insufficient sample sizes of these 
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subgroups (see Results). Finally, AOD users hospitalised after a head injury were compared 
to those without serious head injuries. 
 
3. Results 
3.1 Preliminary analyses 
MoCA data were available for 128 AOD residents and 37 controls. For some 
analyses, the AOD sample was reduced to 95 due to missing data (e.g. primary substance of 
misuse, n=16; SDS and K10 scores, n=33). Table 1 displays demographic, substance use, 
psychological, and cognitive functioning variables for the AOD group. AOD residents were 
in their mid-thirties on average and predominantly male. Alcohol was the primary substance 
of misuse for almost one-third of the sample, followed by heroin and amphetamine misuse, 
with these three substances accounting for approximately 80% of the entire AOD sample. 
The mean K10 score indicated very high levels of psychological distress and the mean SDS 
score indicated high levels of psychological dependence on participants’ primary substance 
of misuse, although the range extended to 0 in some cases, reflecting that some residents had 
progressed further in their treatment. The prevalence of head injuries was particularly high in 
the sample. Of the 67.2% who had either lost consciousness or sustained a concussion after a 
head injury, the mean number of times this had occurred was 4.98 (SD = 5.95). Half of the 
total sample had been hospitalised after sustaining a head injury. 
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Table 1 
Demographic, substance use, psychological, and clinical variables for the AOD group (N = 128) 
Age (Mdn, range)    35 (19-56) 
Gender (% male)     70.3 
Education (Mdn, range)    10 (7-16) 
Unemployed (%)     90.5    
Homelessa (%)         7.4    
Arrested during last three monthsa (%)  43.2           
Primary substance of misuseb (%)     
Alcohol     30.4    
       Heroin     27.7    
       Amphetamines    20.5    
      Cannabis       8.9    
      Tranquilisers        4.5    
      Methadone       2.7    
      Buprenorphine        1.8    
       Cocaine        1.8    
       Benzodiazepines        1.8    
SDSc scorea (Mdn, range)    11 (0-15)   
History of overdose (%)    60.2    
Injected during last three months (%)  52.6    
K10d scorea (M, SD)    29.2 (7.8)    
Hospitalised after head injury (%)   50    
Lost consciousness/concussion after head injury (%) 67.2    
a N = 95 
b N = 112. 
c Severity of Dependence Scale. 
d Kessler Psychological Distress Scale. 
 
All control participants were screened to ensure that they had not been dependent on 
alcohol or other substances and/or received treatment for substance use disorder in the past. 
No control participant currently used any substance (excluding alcohol and tobacco) on a 
regular basis (i.e., greater than once a month), with minimal prior experimentation with 
drugs, and 76% drank alcohol less than twice per week. The 24% of control participants who 
drank alcohol more than once per week were screened to ensure that their current drinking 
was not occurring at a problematic level that caused clinically significant impairment or 
distress. Despite attempts to match sample characteristics, controls were significantly 
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younger (Mdn = 25 years, range 21-61) than the AOD group (Mdn = 35 years, range 19-56), 
z = -5.21, p < .001, and had significantly more years of education (Mdn = 12 years vs. Mdn = 
10 years), z = -4.26, p < .001. Gender distribution did not differ significantly between groups 
(54% male in controls vs. 70.3% male in AOD). Age and education were therefore included 
as covariates for group comparisons. Psychological distress was low to moderate in controls 
(K10 mean 17), and was significantly higher in AOD residents (K10 mean 29), F(1, 130) = 
33.33, p = < .001. 
3.2 Primary analyses 
3.2.1 Covariates 
Despite the group difference in age, age was not significantly correlated with total 
MoCA score, p = .16. It was also not correlated with any MoCA subscores, all p > .05, in the 
entire sample as well as in the AOD group alone. There were significant correlations between 
years of education and total MoCA score, r = .18, p = .02, executive function, r  = .36, p < 
.001, short-term memory, r = .18, p = .02, working memory, r  = .21, p = .006, and language, 
r = .26, p = .001. Age and education were both included as covariates in analyses, but while 
education was consistently significant in the models, age was not. Age was subsequently 
dropped from the analyses and results are reported here with education alone as the covariate 
in analyses of MoCA outcomes for the AOD vs. control group. 
3.2.2 MoCA scores 
Comparison of the AOD and control group determined a significant difference in total 
MoCA score, F(1, 163) = 5.28, p = .023, the combined executive function/visuospatial 
subscore, F(1, 163) = 6.91, p = .009, and the visuospatial domain alone, z = -2.43, p = .015, 
with poorer performance in the AOD group (Table 2). None of the other cognitive domain 
subscores differed between groups: short-term memory, F(1, 163) = .25, p = .62, working 
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memory, F(1, 163) = .27, p = .60, and language, F(1, 163) = 1.04, p = .31. There was a trend 
toward poorer executive function in the AOD group, F(1, 163) = 3.01, p = .08. 
Table 2 
Comparison of MoCA scores between AOD and control groups, for entire AOD sample and those without head 
injuries: mean (SD) 
   
   Head Injuries included  Head injuries excluded  
   AOD group (N = 128)  AOD group (N = 64) Control (N = 37) 
Total score  25.60 (3.13)*   26.39 (2.56)  26.94 (3.10) 
Executive/Visuospatial   5.13 (1.57)**     5.53 (1.47)    6.14 (1.64) 
Executive    2.48 (1.05)     2.73 (1.03)    3.08 (0.92) 
STMa     3.63 (1.33)     3.78 (1.23)    3.92 (1.23) 
WMb     5.36 (1.06)     5.50 (1.04)    5.43 (0.99) 
Visuospatial    2.64 (1.01)*     2.80 (0.98)    3.05 (1.13) 
Language    5.01 (0.94)     5.16 (0.88)    5.35 (0.82)  
*p < .05 **p < .01  
a Short-term memory 
b Working memory 
 
3.2.3 Gender effects 
There were no significant differences between male and female AOD participants in 
age, years of education, or SDS scores (all p > .28). Females tended to have higher K10 
scores (M = 31.25, SD = 7.89) than males (M = 28.21, SD = 7.60), t(93) = -1.82, p = .07. 
MoCA outcomes for males vs. females were not significantly different (all p > .10) although 
females tended to score slightly higher than males (Mdn 3 vs. 2) on executive subscores, z = -
1.68, p = .09. 
 3.2.4 Primary substance of misuse 
 There were significant differences between primary substance of misuse groups in 
age, F(2, 92) = 8.25, p = .001, but not years of education, H(2) = 4.15, p = .13, or SDS scores, 
H(2) = 1.59, p = .45; age was therefore included as a covariate in the analysis. There were no 
significant differences in total MoCA score, F(2, 92) = .04, p = .96, short-term memory, F(2, 
92) = .09, p = .92, language, F(2, 92) = .15, p = .86, executive function, F(2, 92) = 1.37, p = 
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.26, visuospatial abilities, F(2, 92) = 1.61, p = .21, or  combined executive 
function/visuospatial abilities, F(2, 92) = 1.30, p = .28, between primary substance of misuse 
groups (Table 3). There was a marginally significant difference for working memory 
performance, F(2, 92) = 2.98, p = .056, with the poorest performance in the stimulants group. 
K10 scores were significantly different across substance of misuse groups, F(2, 77) = 5.96, p 
= .004, being higher in the stimulant group relative to the opiate group (p = .022) and the 
alcohol group (p = .07), with no difference between alcohol and opiate groups (p = .69). 
Table 3 
Comparison of MoCA scores across primary substance of misuse groups: mean (SD) 
   
   Alcohol (N = 34)   Opiates (N = 36)   Stimulants (N = 25)  
Total score  25.85 (3.49)  25.92 (2.55)  25.88 (3.23) 
Executive/Visuospatial   5.09 (1.73)    5.14 (1.51)    5.60 (1.58) 
Executive    2.26 (1.14)    2.64 (1.05)    2.68 (1.11) 
STMa     3.76 (1.18)    3.69 (1.35)    3.64 (1.31) 
WMb     5.53 (1.08)    5.56 (0.69)    5.00 (1.22) 
Visuospatial    2.82 (0.94)    2.50 (1.06)    2.92 (0.91) 
Language    5.12 (0.95)    4.94 (1.01)    4.96 (0.93) 
a Short-term memory. 
b Working memory; trend toward greater impairment in the stimulants group p=.056. 
 
3.3 Exploratory analyses 
3.3.1 Psychological distress and substance dependence 
There were significant negative correlations between K10 scores and total MoCA 
scores, r = -.22, p = .012, executive function/visuospatial abilities, r = -.21, p = .015, and 
language scores, r = -.20, p = .021, and a trend for working memory, r = -.16, p = .06, in the 
overall AOD sample. K10 and SDS scores were positively correlated, r = .20, p = .049, but 
SDS scores were not correlated with any MoCA scores (all p > .05), other than a trend toward 
a correlation with executive function, r = .18, p = .085. This pattern indicates that greater 
psychological distress (but not greater drug dependence) is associated with greater cognitive 
impairment. 
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3.3.2 Head injuries 
Given that 50% of the AOD sample had been hospitalised for a head injury, the 
impact of head injuries on cognitive function were imperative to investigate further. There 
were no significant differences in age, z = -1.24, p = .22, education, z = -.94, p = .35, or K10 
scores, t(93) = -.23, p = .82, between AOD residents who had versus had not been 
hospitalised after a head injury, but those who had not been hospitalised for head injury had 
higher SDS scores, z = -2.10, p = .035, (Mdn = 11 vs. 10). AOD participants who had been 
hospitalised had lower total MoCA scores (Mdn = 25.5 vs. 26), z = -2.59, p = .01, than those 
who had not. The hospitalised group also had lower executive/visuospatial (Mdn = 5 vs. 6, z 
= -2.97, p = .003), working memory (Mean Rank = 58.38 vs. 70.62, z = -2.18, p = .03), and 
executive (Mdn = 2 vs. 3, z = -2.66, p = .008) subscores, than the non-hospitalised group, 
with trends toward lower language, z = -1.67, p = .095, and visuospatial subscores, z = -1.71, 
p = .088, but no difference in short-term memory subscores, z = -1.17, p = .24. Figure 1 
displays standardised (out of 6) MoCA domain scores for AOD participants hospitalised for 
head injuries, non-hospitalised AOD participants and controls. 
 3.3.3 Analysis of sample without significant head injuries 
 After exclusion of those who had been hospitalised after a head injury, the primary 
analyses were repeated to compare only those AOD residents who had not sustained head 
injures requiring hospitalisation with controls (Table 2). The AOD group in this reduced 
sample (n = 64) were significantly older than controls (Mdn = 34 vs. 25, respectively), z = -
4.82, p = < .001, and less educated (Mdn = 10 vs. 12), z = -3.65, p = < .001. With age and 
education included as covariates, there were no significant differences in total MoCA score, 
F(1, 99) = .38, p = .54, or any MoCA subscores (all p > .20) between AOD residents without 
significant head injuries and controls. Significant differences remained for K10 scores 
between these AOD residents (Mdn = 29) and controls (Mdn = 16), F(1, 82) = 33.51, p = < 
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.001. Other than males scoring significantly higher (Mean Rank = 36.43) in working memory 
subscores than females (Mean Rank = 25.50), z = -2.91, p = .004, no other effects of gender 
or primary substance of misuse were found in this sample without head injuries. 
 3.3.4 Clinical significance of impairment 
 To investigate the clinical significance of impairment, total MoCA scores were 
recoded as a dichotomous variable to indicate either the presence or absence of cognitive 
impairment according to the cut-off score suggested by Copersino et al. (2009) as ≥ 26 
reflecting no evidence of cognitive impairment. Within the overall AOD group, 43.8% met 
criteria for cognitive impairment. After removing those hospitalised for head injuries, 37.5% 
met criteria for impairment and this represented a significantly greater proportion than the 
16.2% of controls meeting criteria for impairment, χ²(1, N = 101) = 5.09, p = .019. However, 
after removing a further 27 participants in the AOD sample who had sustained concussion or 
lost consciousness after a head injury but had not been hospitalised, the prevalence of 
impairment dropped to 29.7% and this did not represent a statistically significant difference 
when compared to the 16.2% of impaired controls (p = .13). Subsequently, it was deemed 
appropriate to examine the prevalence of impairment within the AOD group who had been 
hospitalised after a head injury. Of those who had been hospitalised (n = 64), only 50% met 
criteria for cognitive impairment, indicating that hospitalisation for head injuries alone may 
not predict cognitive impairment. There was no difference in the total number of head 
injuries (including those that did not require hospitalisation) sustained by those who met 
criteria for impairment (Mdn = 3) vs. those who did not (Mdn = 3), p = .67. 
 
4. Discussion 
 This study used a brief screening tool, the MoCA, to provide an overview of cognitive 
functioning in residents of a substance misuse TC. The major findings were that 43.8% of the 
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AOD group met criteria for cognitive impairment and head injuries were a significant 
determinant of this impairment. Within the AOD group, 50% had been hospitalised after a 
head injury and were more cognitively impaired than those who had not sustained head 
injuries requiring hospitalisation. Greater psychological distress in the AOD group was also 
associated with greater cognitive deficits. 
4.1 Neuropsychological functioning  
 AOD residents overall scored significantly lower on the MoCA and showed greater 
deficits in executive function and visuospatial abilities than controls. No other cognitive 
domains differed between residents and controls. Within the AOD group, there were no 
gender effects other than a trend toward males displaying greater executive dysfunction than 
females and females tended to have higher levels of psychological distress than males. MoCA 
outcomes did not differ according to primary substance of misuse, other than stimulant users 
showing marginally poorer working memory ability and higher levels of psychological 
distress. The lack of observed differences in neuropsychological outcomes between substance 
of misuse groups may be explained by the prevalence of polysubstance use in clients 
undergoing residential AOD treatment; differences may not be detected between groups in 
which substance use has reached a level necessitating residential treatment. Generally, clients 
in residential AOD treatment have extensive histories of substance use with considerable 
variability between individuals. Another possible explanation is that differences do exist 
between substance of misuse groups in residential treatment but that the current study did not 
possess group sizes large enough to detect these differences. 
 4.1.1 Head injuries 
Half of the AOD sample in the current study had been hospitalised after a head injury 
and were more cognitively impaired than those who had not, with lower total MoCA scores, 
and poorer executive/visuospatial and working memory abilities. When the hospitalised 
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group were excluded from the analysis, there were no differences in any neuropsychological 
outcomes between AOD residents and controls, and no differences between primary 
substance of misuse groups, but females in this subset displayed poorer working memory 
performance than males. 
In general, these findings are congruent with the literature suggesting that cognitive 
impairments exist in AOD populations (Caplan et al., 2007; Ersche & Sahakian, 2007; 
Fernández-Serrano et al., 2010b; Gonzalez, 2007; Gruber et al., 2007; Oscar-Berman & 
Marinković, 2007; Scott et al., 2007; Yücel & Lubman, 2007; Yücel et al., 2007) and may be 
detected by a brief cognitive impairment-screening tool (the MoCA). In assessing a 
residential AOD sample, arguably we accessed those most severely affected by their 
addiction, and also those with a high prevalence of head injuries requiring hospitalisation. 
The level of cognitive impairment detected in this sample, as measured by the MoCA, was 
not severe and was largely associated with TBI, a factor that has not routinely been 
considered in previous studies and may account for a significant portion of the deficits 
observed in the literature. 
4.2 Implications 
 This study showed that having sustained a TBI requiring hospitalisation accounted for 
the majority of cognitive impairment detected in the sample. There are two major 
implications: first, simply asking clients whether they have ever sustained a head injury 
requiring hospitalisation may be the most time-efficient way to informally gauge the 
possibility of cognitive deficits. Clients may be unable, however, to provide accurate 
accounts due to the high rate of TBIs occurring during intoxication that may remain 
undetected and receive no medical intervention. Whilst half of the AOD group in the current 
study had sustained a head injury requiring hospitalisation, 50% of this subgroup did not 
meet criteria for impairment based on the MoCA score threshold. As such, screening for head 
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injuries alone without subsequent cognitive assessment may lead to inflated estimates of 
impairment. Furthermore, this type of screening would not capture approximately one third of 
the AOD sample that had never sustained head injuries and yet met criteria for cognitive 
impairment. Thus, the second implication is that cognitive deficits may also exist 
independently of head injuries in AOD samples and hence require screening in their own 
right. 
These complex findings highlight the importance of brief cognitive screening as a 
standardised assessment procedure for all clients entering residential treatment. In this way, 
treatment planning may account for the presence of cognitive deficits. Further 
neuropsychological assessment may be recommended and modifications to treatment and/or 
targeted interventions may be implemented. 
Regardless of the aetiology of cognitive impairment, cognitive screening has the 
potential to inform interventions aimed at alleviating these deficits. For example, adjunct 
interventions to remediate cognitive deficits together with better-tailored specific treatments 
may bolster residential services, reducing dropout rates and consequently improving 
treatment outcomes. Evidence suggests that the neuropsychological deficits associated with 
TBI can be alleviated through cognitive remediation interventions (Maas et al., 2013; Manley 
& Maas, 2013; Tsaousides & Gordon, 2009), and there is emerging evidence for the use of 
cognitive remediation programs in substance misuse populations as a way to improve 
treatment retention (Bates, Buckman, & Nguyen, 2013; Fals-Stewart & Lam, 2010; Rupp, 
Kemmler, Kurz, Hinterhuber, & Fleischhacker, 2012; Verdejo-García, 2011; Wexler, 2011). 
Further research aimed at developing and trialling cognitive remediation programs for AOD 
populations is required and providing these interventions within residential treatment services 
would be most ideal (e.g., Gonçalves et al., 2014). 
4.3 Limitations and future directions 
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 There are several limitations of the current study. There were clear differences 
between the AOD group and controls (e.g., age, education, inferred socioeconomic status). 
While some of these differences were accounted for statistically, future research would 
benefit from the inclusion of better-matched control groups. The exploration of primary 
substance of misuse groups resulted in small sample sizes with reduced statistical power for 
comparison; larger samples in future studies may reveal substance-specific impairment. 
Another limitation of the current study is its failure to assess for psychiatric comorbidities, 
which are common in AOD populations and add substantial complexity to the process of 
treatment. The current study utilised the K10 as a measure of psychological distress and 
higher scores were associated with greater cognitive impairment. Future studies should 
include formal psychiatric diagnoses in order to examine their interaction with substance use 
disorders and head injuries in terms of cognitive outcomes. Additionally, the current study 
focused on hospitalisation and frequency of head injuries, but not their nature, severity or age 
of occurrence, which could be further examined in future studies. Also, despite the AOD 
sample being abstinent from AOD, there was no assessment of their duration of abstinence or 
length of stay in residential services prior to cognitive assessment; this, along with a more 
detailed substance use history (including age of onset and number of years of substance use) 
and objective measures of abstinence (e.g. urine testing in both AOD and control samples), 
could have provided further information regarding the nature and extent of the observed 
cognitive deficits. Finally, the potential lack of sensitivity of the MoCA to more specific 
cognitive deficits in AOD populations cannot be underestimated; the scores observed in this 
sample were not substantially below the cut-off indicative of impairment. Nevertheless, the 
MoCA can serve as a cost-effective screening tool that would detect severe deficits in those 
most requiring further neurocognitive assessment. 
4.4 Conclusion 
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 The current study identified that the MoCA may be usefully applied in the AOD 
treatment setting as a brief screening tool. We showed in a naturalistic snapshot of clients in 
AOD residential treatment that cognitive impairment is common and may be related to the 
effects of head injuries, which are also highly prevalent. Cognitive abilities such as executive 
function and working memory are important for AOD residents to engage meaningfully in 
treatment and achieve successful outcomes. If these capacities are compromised, residents 
may be more likely to drop out from treatment and fail to recover from their addiction. The 
first step in rectifying this situation is to improve the assessment and detection of those who 
present with cognitive deficits. This will help to inform modifications to treatment and/or 
cognitive remediation interventions that may be beneficial in accommodating and potentially 
remediating impairments in cognition, increasing the likelihood of treatment engagement and 
retention, and hopefully leading to long-term recovery from addiction. 
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